Dobutamine positron emission tomography: Absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease

Journal of the American College of Cardiology

Volumn 28, Issue 3, 1996, Pages 565-572

  Krivokapich, Janine ^a   Czernin, Johannes ^a   Schelbert, Heinrich R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HEART WORK; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030245556     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00205-7     Document Type: Article

References (23)

1. 1. Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using N-13 ammonia and C-11 acetate. Am J Cardiol 1993;71:1351-6.
2. 2. Yonekura Y, Tamaki N, Senda M, et al. Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomography. Am Heart J 1987;113:645-54.
3. 3. Krivokapich J, Huang SC, Ratib O, Schelbert HR. Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. Am Heart J 1991;122:202-11.
4. 4. Schelbert HR, Wisenberg G, Phelps ME, et al. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation: VI. Detection of coronary artery disease in man with intravenous 13-NH3 and positron computed tomography. Am J Cardiol 1982;49: 1197-207.
5. 5. Gould KL, Goldstein RA, Mullani NA, et al. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary voasodilation: VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. J Am Coll Cardiol 1986;7:775-89.
6. 6. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31:1899-905.
7. 7. Marwick TH, Nemec JJ, Stewart WJ, Salcedo E. Diagnosis of coronary artery disease using exercise echocardiography and positron emission tomography: comparison and analysis of discrepant results. J Am Soc Echocardiogr 1992;5:231-8.
8. 8. Gupta NC, Esterbrooks D, Mohiuddin S, et al. Adenosine in myocardial perfusion imaging using positron emission tomography. Am Heart J 1991; 122:293-301.
9. 9. Krivokapich J, Smith GT, Huang SC, et al. 13N ammonia mayocardial imaging at rest and with exercise in normal volunteers: Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989;80:1328-37.
10. 10. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic PET imaging. J Am Coll Cardiol 1990;15:1032-42.
11. 11. Chan SY, Brunken RC, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal human subjects. J Am Coll Cardiol 1992;20:979-85.
12. 12. Czernin J, Porenta G, Brunken R, et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation 1993;88:884-95.
13. 13. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989;14:639-52.
14. 14. Araujo LI, Lammertsman AA, Rhodes CG, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991;83:875-85.
15. 15. McFalls EO, Araujo LI, Lammertsma A, et al. Vasodilator reserve in collateral-dependent myocardium as measured by positron emission tomography. Eur Heart J 1993;14:336-43.
16. 15O. J Am Coll Cardiol 1990;15:119-27.
17. 17. Seneff MJ, Hartman J, Sobel BE, Geltman EM, Bergmann SR. Persistence of coronary vasodilator responsivity after cardiac transplantation. Am J Cardiol 1993;71:333-8.
18. 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992;86:1004-17.
19. 19. Porenta G, Kuhle W, Czernin J, et al. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. J Nucl Med 1992;33:1623-31.
20. 20. Maddahi J, Van Train K, Prigent F, et al. Quantitative single photon emission computed thallium-201 tomography for detection and location of coronary artery disease: optimization and prospective validation of a new technique. J Am Coll Cardiol 1989;14:1689-99.
21. 21. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983;64:766-78.
22. 22. Peterson KL, Rivera I, McDaniel M, et al. Early follow-up at 24 hours by quantitative angiography. In: Reiber JHC, Serruys PW, editors. Advances in Quantitative Coronary Arteriography. Dordrecht (The Netherlands): Kluwer, 1993:497-513.
23. 23. Di Carli M, Czernin J, Hoh CK, et al. Relationship among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.